CellaVision Valuation
| CEVI Stock | SEK 149.20 4.20 2.74% |
At this time, the firm appears to be fairly valued. CellaVision AB shows a prevailing Real Value of kr153.75 per share. The current price of the firm is kr149.2. Our model approximates the value of CellaVision AB from analyzing the firm fundamentals such as Profit Margin of 0.19 %, current valuation of 6.21 B, and Return On Equity of 0.2 as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that CellaVision's price fluctuation is very steady at this time. Calculation of the real value of CellaVision AB is based on 3 months time horizon. Increasing CellaVision's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
CellaVision's intrinsic value may or may not be the same as its current market price of 149.20, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 149.2 | Real 153.75 | Hype 153.4 |
The intrinsic value of CellaVision's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence CellaVision's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of CellaVision AB helps investors to forecast how CellaVision stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CellaVision more accurately as focusing exclusively on CellaVision's fundamentals will not take into account other important factors: About CellaVision Valuation
The stock valuation mechanism determines CellaVision's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of CellaVision AB based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of CellaVision. We calculate exposure to CellaVision's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CellaVision's related companies.CellaVision AB develops and sells digital solutions for blood and body fluids analysis in health care services sector in Sweden and internationally. CellaVision AB was founded in 1994 and is headquartered in Lund, Sweden. CellaVision operates under High Precision And Instrumentation Products classification in Sweden and is traded on Stockholm Stock Exchange. It employs 129 people.
8 Steps to conduct CellaVision's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates CellaVision's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct CellaVision's valuation analysis, follow these 8 steps:- Gather financial information: Obtain CellaVision's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine CellaVision's revenue streams: Identify CellaVision's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research CellaVision's industry and market trends, including the size of the market, growth rate, and competition.
- Establish CellaVision's growth potential: Evaluate CellaVision's management, business model, and growth potential.
- Determine CellaVision's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate CellaVision's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for CellaVision Stock Analysis
When running CellaVision's price analysis, check to measure CellaVision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CellaVision is operating at the current time. Most of CellaVision's value examination focuses on studying past and present price action to predict the probability of CellaVision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CellaVision's price. Additionally, you may evaluate how the addition of CellaVision to your portfolios can decrease your overall portfolio volatility.